Journal of Biological Chemistry · 2006 · 85 citations · 23 references
Life SciencesMedicinal ChemistryPharmacologyDrug DesignEnzymologyStructural BiologyEnzyme FunctionEnzyme InhibitionEnzyme-substrate RecognitionLigand BindingProtein StructureStructural EnzymologyCatalytic Site ArchitecturePhosphatase InhibitionPhosphatasesPhosphonate InhibitorsProtein Backbone Hydrogen BondsProtein Phosphatase CatalysisProtein Tyrosine Phosphatase InhibitorsSmall Molecule Tyrosine Kinase Inhibitors
Crystal structures of protein-tyrosine phosphatase 1B in complex with compounds bearing a novel isothiazolidinone (IZD) heterocyclic phosphonate mimetic reveal that the heterocycle is highly complementary to the catalytic pocket of the protein. The heterocycle participates in an extensive network of hydrogen bonds with the backbone of the phosphate-binding loop, Phe(182) of the flap, and the side chain of Arg(221). When substituted with a phenol, the small inhibitor induces the closed conformation of the protein and displaces all waters in the catalytic pocket. Saturated IZD-containing peptides are more potent inhibitors than unsaturated analogs because the IZD heterocycle and phenyl ring directly attached to it bind in a nearly orthogonal orientation with respect to each other, a conformation that is close to the energy minimum of the saturated IZD-phenyl moiety. These results explain why the heterocycle is a potent phosphonate mimetic and an ideal starting point for designing small nonpeptidic inhibitors.
23
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
Insulin signalling and the regulation of glucose and lipid metabolism
Alan R. Saltiel, C. Ronald Kahn · Nature · 2001 · 5.3K citations · Full text
Lori D. Klaman, Olivier Boss, Odile D. Peroni et al. · Molecular and Cellular Biology · 2000 · 1.2K citations
Crystal Structure of Human Protein Tyrosine Phosphatase 1B
David Barford, Andrew Flint, Nicholas K. Tonks · Science · 1994 · 759 citations